Forward steps are being made in HNSCC, and the first patient with MDS has been treated with iadademstat/azacitidine.

If you are worried about using this medicine, speak to your doctor or pharmacist. Azacitidine-Teva contains the active ingredient azacitidine. Azacitidine-Teva is used to treat myelodysplastic ...

For information, the company have announced that the STIMULUS program for Sabatolimab with azacitidine for untreated high-risk myelodysplastic syndromes has been terminated and therefore they will no ...

Patients were treated in the dose-escalation portion of the Phase 1/2 study evaluating seclidemstat in combination with azacitidine Investigators reported a 43% overall response rate among 14 ...

Citing Phase 1 data the company announced, Citi analyst Yigal Nochomovitz noted that SL-172154 with chemotherapy azacitidine ...

Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and ...